##  [Approximately 80% of psoriatic arthritis patients treated with Cosentyx® saw no progression of joint damage as shown in Novartis new two-year observational data](/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0 "Approximately 80% of psoriatic arthritis patients treated with Cosentyx® saw no progression of joint damage as shown in Novartis new two-year observational data") 

  Nov 07, 2015